Partner Content Contrast-Induced Acute Kidney Injury: Preventive Measures that Work in High Risk Patients - Osprey/Abiomed November 12, 2019
Partner Content Treating the Complex Patients: Impella-Enabled Complete Revascularization - Abiomed November 12, 2019
Partner Content Optimizing LDL-C Management in Patients Undergoing Revascularization: More Than Just the Metal - Amgen November 6, 2019
Partner Content Transforming Robotics Into an Advanced Clinical Tool Through Automation & Remote Capabilities - Corindus October 29, 2019
Video » Reducing Aspirin Use in ACS and PCI (With and Without AFib): How Good Is the Evidence? October 16, 2019
Video » Topical Discussion SYNERGY BP-DES & Optimizing Antiplatelet Therapy after PCI in High-Bleeding Risk Patients October 8, 2019
Video » IVUS-XPL: 5-Year Outcomes From a Randomized Trial of Intravascular Ultrasound-Guided vs. Angiography-Guided PCI of Long Coronary Lesions September 29, 2019
Video » BLADE-PCI: A Randomized Trial of Liposomal Alendronate in Patients With Diabetes Undergoing PCI September 29, 2019
Video » Interview Dr. C. Michael Gibson Talks With Dr. Gregg W. Stone About EXCEL: 5-Year Outcomes From a Randomized Trial of PCI vs. CABG in Patients With Left Main Coronary Artery Disease September 29, 2019
Video » Interview Dr. C. Michael Gibson Talks With Dr. Usman Baber About the TWILIGHT Thrombogenicity Substudy: Impact of Ticagrelor Alone vs. Ticagrelor Plus Aspirin on Ex-Vivo Blood Thrombogenicity in High-Risk Patients Undergoing PCI September 28, 2019
Video » Interview Dr. C. Michael Gibson Talks With Dr. Myeong-Ki Hong About IVUS-XPL: 5-Year Outcomes From a Randomized Trial of Intravascular Ultrasound-Guided vs. Angiography-Guided PCI of Long Coronary Lesions September 28, 2019
Video » Interview Dr. C. Michael Gibson Talks With Dr. David Wood About the COMPLETE Timing Substudy: A Randomized Trial of Complete Staged Revascularization vs. Infarct Artery PCI Alone in Patients With Acute Myocardial Infarction and Multivessel Disease September 28, 2019
Video » Interview Dr. C. Michael Gibson Talks With Dr. Roxana Mehran About TWILIGHT: A Randomized Trial of Ticagrelor Monotherapy vs. Ticagrelor Plus Aspirin Beginning at 3 Months in High-Risk Patients Undergoing PCI September 27, 2019
Partner Content Is Physiologic Guidance the Solution to Residual Ischemia? A Closer Look at DEFINE PCI March 21, 2019
Video » Interview ACC 2019: The DEFINE PCI Trial: Blinded Physiologic Assessment of Residual Ischemia After Successful Angiographic Percutaneous Coronary Intervention March 18, 2019